Coeptis Therapeutics Holdings, Inc. - Common Stock (COEP)
7.7000
-4.7700 (-38.25%)
NASDAQ · Last Trade: Apr 26th, 11:27 AM EDT
Via Benzinga · April 25, 2025
Via Benzinga · March 24, 2025

Coeptis Therapeutics shares rise after acquiring NexGenAI platform and launching Coeptis Technologies to enhance marketing in regulated industries.
Via Benzinga · December 26, 2024
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via Chartmill · March 17, 2025
Via Benzinga · March 17, 2025

The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill · February 20, 2025

Via Benzinga · January 3, 2025

Via Benzinga · January 3, 2025

Via Benzinga · December 27, 2024

Coeptis Therapeutics stock drops 22.5% after announcing a 1-for-20 reverse stock split to meet Nasdaq's listing requirements.
Via Benzinga · December 27, 2024

Via Benzinga · December 26, 2024

Via Benzinga · December 12, 2024

Coeptis Therapeutics just reported results for the second quarter of 2024.
Via InvestorPlace · August 16, 2024

It's time to dive into the biggest pre-market stock movers on Thursday morning with all of the latest news this morning!
Via InvestorPlace · August 8, 2024

Via Benzinga · August 8, 2024

Via Benzinga · May 22, 2024

Coeptis Therapeutics just reported results for the first quarter of 2024.
Via InvestorPlace · May 13, 2024

Via Benzinga · April 4, 2024

COEP stock results show that Coeptis Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
Via InvestorPlace · April 1, 2024

Via Benzinga · March 26, 2024

Via Benzinga · March 14, 2024

Via Benzinga · February 12, 2024

Via Benzinga · February 8, 2024